重大公告
Clarification on the news articles by Commercial Times, United Daily, etc.
Date of occurrence of the event:2018/02/23 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A Reciprocal shareholding …
FDA Clearance of IND Application for A Phase 1 Study of A Monoclonal Antibody Cancer Immunotherapy (OBI-888)
Date of occurrence of the event: January 17, 2018 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): …
Shilin District Court deny OBI’s request to submit the case for trial
Defendant: Reporter Pei amongst the other six reporters Name of the legal agency or court: Taiwan Shilin District Court Reference/case numbers of relevant documents: 2017 …
OBI Pharma Inc. to attend the investor conference on new drug development, hosted by Masterlink Securities
Date: January 16, 2018 Date of the event: Jan 16, 2018 Time: 14:00:00 (Taiwan Time) Location：Courtyard Marriott Taipei Summary: OBI Pharma Inc. to attend the …
Capital increase for new shares to transfer to AP Biosciences, Inc.
Type of merger/acquisition (e.g. merger, consolidation, spin-off,acquisition, or receiving assignment of shares): Receiving assignment of shares Date of occurrence of the event: Dec 29, 2017 …